Polity3 November 20265 min read
Health Ministry Proposes Twin Amendments to Drugs Rules, 1945 to Fix Batch Release Gap and Expand Import Gateways
The Union Ministry of Health and Family Welfare has proposed two separate amendments to the Drugs Rules, 1945, each targeting a distinct weakness in India's pharmaceutical regulatory architecture. Both draft notifications have been published in the Official Gazette and are open for public objections and suggestions, which may be sent to the Under Secretary (Drugs Regulation) at the Ministry or submitted by email.
Closing the Batch-Release Accountability Gap
The first amendment addresses a gap that has persisted in the existing rules. Manufacturers seeking a licence are already required to furnish details of competent technical staff responsible for manufacturing and testing, but no provision currently obliges them to designate a person specifically accountable for batch release. That is the stage at which a batch's quality parameters and documentation are reviewed before it is cleared for distribution. The proposed amendment would require licence applicants to formally designate a suitably qualified and experienced person for this function.
Alongside that designation, manufacturers would be required to maintain batch-release records in a prescribed form. The rules would also introduce a standardised Batch Release Certificate format. The Ministry says the changes are intended to establish clear responsibility for batch-release decisions, ensure traceability, and provide an additional layer of oversight over product quality — all of which are expected to strengthen manufacturer compliance with Good Manufacturing Practices (GMP), which govern the conditions under which pharmaceutical products must be produced and controlled.
New Entry Points for Drug Imports
The second amendment proposes an expansion of Rule 43A of the Drugs Rules, 1945, which lists the authorised ports, airports, railway stations, road crossings and other entry points through which drugs may be imported into India. The Ministry wants to add several new locations to this network:
- Inland Container Depots (ICDs) at Sonipat, Piyala and Harsaru in Haryana; Dadri in Uttar Pradesh; Gandhidham/Mundra in Gujarat; Sanath Nagar and Thimmapur in Hyderabad, Telangana; and Whitefield in Bengaluru, Karnataka
- SEZ Bommasandra in Karnataka
- Noida International Airport in Uttar Pradesh, specifically for the import of drugs by air
The coverage spans five states and adds both inland and air-entry options. Bringing authorised clearance points closer to importers' manufacturing facilities, warehouses and distribution centres is expected to reduce inland transportation distances, cut logistics costs and minimise delays in moving imported consignments. The Ministry has also framed the expansion as a contribution to ease of doing business and to the timely availability of essential healthcare products across different regions of the country.
Read together, the two amendments reflect a dual regulatory impulse: tightening the chain of human accountability inside the manufacturing process while making it easier and cheaper to bring healthcare products into the country through a wider set of entry points.